3- (5- cyano- 4- (4- methyl- 2- (methylamino)thiazol- 5- yl)pyrimidin- 2- ylamino)benzenesulfonamide

CDK9 inhibitor; structure in first source

Also Known As:

CDKI-71

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/01/2012 - "Significantly, CDKI-71 also demonstrated potent anti-chronic lymphocytic leukemia activity with minimal toxicity in normal B- and T-cells. "
2.	Neoplasms (Cancer) 03/01/2012 - "CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol."

1.	alvocidib (flavopiridol)